Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Choose from credit cards with zero annual fees that offer cash back rewards. Keep all your rewards and maximize your savings.
23,592 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Greg Abel is steering Berkshire’s AI strategy with a sizable move into Alphabet. This bold bet highlights how mega-ca...
If SpaceX goes public, investors will chase big headlines and big moves. History suggests year-one volatility is the ...
In volatile markets, pulling back can create buying opportunities. This article highlights three growth stocks to buy...
Axon Enterprise stock soared higher after a solid earnings beat and a ambitious revenue goal. This article breaks dow...
Burford kicks off 2026 with a solid Q1 showing that sheds light on the company’s revenue mix, profitability, and liqu...
Rivian's R2 rollout marks a new chapter for the EV maker. This guide breaks down whether the stock deserves a place i...
As clean energy climbs, storage plays a pivotal role. This article breaks down why energy stock soaring today points ...
A new Fed chair promises reform, but progress stalls. This article explains the investing implications when it's been...
Markets remain volatile in 2026, pushing investors toward durable, dividend-rich names. This report lays out the best...
Occidental Petroleum surged after announcing a $5.8 billion debt reduction tied to the OxyChem sale and an uptick in ...
Constellation Energy stock climbing today reflects a mix of solid quarterly results and favorable energy-market dynam...